High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach

Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Nisha B., Mitchell, Rhonita E., Proctor, Stephanie Terry, Choi, Leena, DeClercq, Joshua, Jolly, Jacob A., Hemnes, Anna R., Zuckerman, Autumn D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553732/
https://www.ncbi.nlm.nih.gov/pubmed/31170217
http://dx.doi.org/10.1371/journal.pone.0217798

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553732/
https://www.ncbi.nlm.nih.gov/pubmed/31170217
http://dx.doi.org/10.1371/journal.pone.0217798

Ejemplares similares